References
1 Tietz HJ, Küssner A, Thanos M, et al. Phenotypic and genotypic characterization of unusual vaginal isolates of Candida albicansfrom Africa. J Clin Microbiol. 1995; 33: 2462-5.
2 Tietz HJ, Hopp M, Schmalreck A, Sterry W, Czaika V. Candida africana sp. nov., a new human pathogen or variant of Candida albicans? Mycoses. 2001; 44:437-45.
3 Al-Hadaithy SSA, Fotedar R. Recovery and studies on chlamydospore-negative Candida albicans isolated from clinical specimen. Med Mycol.2002; 40: 301-6.
4 Yazdanparast SA, Khodavaisy S, Fakhim H, et al. Molecular characterization of highly susceptible Candida africana from vulvovaginal candidiasis Myycopathologia. 2015; 180: 317-323.
5 Seifi Z, Mahmoudabadi AZ, Halvaeezadeh M. Candida africana , a first case from Iran, susceptibility to antifungals, evaluation extracellular enzymes and biofilm formation. IJAPBS. 2015; 4: 75-80.
6 Mendling W, Krauss C, Fladung B. A clinical multicenter study comparing efficacy and tolerability of topical combination therapy with clotrimazole (Canesten, two formats) with oral single dose fluconazole (Diflucan) in vulvovaginal mycoses. Mycoses. 2004; 47: 136-42.
7 Alonso-Vargas R, Elorduly L, Eraso E, et al. Isolation ofCandida africana , probable atypical strains of Candida albicans , from a patient with vaginitis. Med Mycol. 2008; 46: 167-70.
8 Romeo O, Criseo G. Morphological, biochemical and molecular characterisation of the first Italian Candida africanaisolate. Mycoses. 2009; 52:454-57.
9 Borman AM, Szekely A, Linton CJ, Palmer MD, Brown P, Johnson EM. Epidemiology, antifungal susceptibility, and pathogenicity ofCandida africana isolates from the United Kingdom. J Clin Microbiol. 2013; 51:967-72.
10 Odds FC, Bougnoux ME, Shaw DJ, et al. Molecular phylogenetics ofCandida albicans . Eukaryotic Cell. 2007; 6: 1041-52.
11 Shan Y, Fan S, Liu X, Li J. Prevalence of Candida albicans -closely related yeasts, Candida africana andCandida dubliniensis in vulvovaginal candidiasis. Med Mycol. 2014; 52: 636-40.
12 Sharma C, Muralidhar S, Xu J, Meis JF, Chowdhary A. Multilocus sequence typing of Candida africana patients with vulvovaginal candidiasis in New Delhi, India. Mycoses. 2014; 67: 544-52.
13 Song ES, Shin JH, Jang HC, et al.  Multilocus sequence typing for the analysis of clonality among Candida albicans  strains from a neonatal intensive care unit. Med Mycol. 2014; 52: 653-658.
14 Hu Y, Yu A, Chen X, Wang G, Feng X. Molecular characterization ofCandida africana in genital specimens in shanghai, China. Biomed Res Int. 2015 185387. Doi: 10.1155/2015/185387.
15 Rodríguez-Leguizamón G, Fiori A, López LF, et al. Characterising atypical Candida albicans clinical isolates from six third-level hospitals in Bogotá, Colombia. BMC microbial. 2015; 15:199. doi: 10.11866/s 12866-015-0535-0.
16 Theill L, Dudiuk C, Morano S, et al. Prevalence and antifungal susceptibility of Candida albicans and its related speciesCandida dubliniensis and Candida africana isolated from vulvovaginal samples in a hospital of Argentina. Rev Argent. Microbiol. 2016; 48: 43-49.
17 Dieng Y, Sow D, Ndiaye M, et al. Identification of threeCandida africana strains in Senegal. J Mycologie Med. 2012; 22: 335-40.
18 Nnadi NE, Ayanbimpe GM, Scordino F, et al. Isolation and molecular characterization of Candida africana from Jos, Nigeria. Med Mycol. 2012; 50:765-7.
19 Ngounana TK, Krasteva D, Drakulovski P, et al. Investigation of minor species Candida africana , Candida stellatoidea andCandida dubliniensis in the Candida albicans complex among Yaounde (Cameroon) HIV-infected patients Mycoses. 2015; 58: 33-9.
20 Hazen K. Novel yeast, originally detected in Africa, now isolated from weman in the United States In: The 3rdInterscience conference on Antimicrobiol Agents and Chemotherapy (ICAAC). 2013; Sep 10-13 Denver, Co, USA.
21 Romeo O, Tietz HJ, Criseo G. Candida africana : is it a Fungal Pathogen? Curr Fungal Infect Rep. 2013; 7: 192-7.
22 Gumral R, Sancak B, Guzel AB, SaraçhMA, Ilkit M. Lack ofCandida africana and Candida dubliniensis in vaginalCandida albicans isolates in Turkey using HWP1 gene polymorphisms.Mycopathologia. 2011; 172: 73-6.
23 Yazdanpanah A, Khaithir TM. Issues in identifying germ tube positive yeasts by conventional methods. J. Clin Lab Anal. 2014; 28: 1-9.
24 Chowdhary A, Hagen F, Sharma C, et al. Whole genome-based amplified length polymorphism analysis reveals genetic diversity in Candida africana . Frontiers Microbiol. 2017; 8: 1-8.
25 Giosa D, Felice MR, Lawrence TJ, et al. Whole RNA-sequencing and transcriptome assembly of Candida albicans and Candida africana under chlamydospore-inducing conditions. Genome Biol. Evol. 2017; 9(7): 1971-77.
26 Al-Duboon AH. The etiological agents of Otomycosis in Basrah (Iraq). Basrah J Sci. 2000; 18(2): 1-6.
27 Abdullah SK, Khudor MH, Al-Salman M. The role of some predisposing and risk factors in incidence of vulvovaginal candidiasis in Basrah women. Basrah J Sci. 2001; 19(1): 25-34.
28 Khudor MH, Al-Salman M, Abdullah SK. Incidence and species distribution of vaginal yeasts in Basrah women. Iraq J Biol. 2002; 2(2): 212-19.
29 Khudor MH, Abdullah SK, Al-Salman M. Incidence of Candida and other yeasts in urine of asymptomatic pregnant women in Basrah city. Basrah J Sci. 2000; 20(1): 47-52.
30 Muhsin TM, Al-Duboon AH, Al-Rubaiy KK. Cutaneous candidiasis from Basrah, Iraq. Iraqi J Biol. 2003; 3(1): 135-39.
31 Al-Abbasi AM, Al-Saadoon AH, Sabbar BA. Otomycosis in Basrah-Iraq. JABHS. 2011; 12(2): 28-33.
32 Abdul-Raheem BS. A study on occurrence of Candida species in the oral cavity of diabetic patients in Basrah. M. Sc. Thesis. College of Science, University of Basrah. 2012; 104pp.
33 Alrubayae I, Al-Duboon AH, Majed M. Study of Candida spp. associated with urinary tract infections in Basra: Urinary tract infection associated with Candida spp.: Their identification, pathogenicity and susceptibility to antifungals. Lambert Acad. Pub. 2013; 224pp.
34 Hasan AM, Al-Jubouri MH. Isolation of Candida spp. from patients with different types of Leukemia who suffered oral candidiasis due to their weekend immune system. J Pharm Chem Biol Sci. 2015; 3(1):79-83.
35 Mohammed BL, Bander KI, Hamad TA. Determine phospholipase and aspartic proteinases activity as virulence factors in Candidaspecies isolated from vaginal infection in Kirkuk City. Worl J Pharm Pharmaceut Sci. 2015; 4(12): 260-273.
36 Aldossary MA, Almansour NA, Abdulraheem BS. Isolation and identification of Candida species from the oral cavity of cancer patients undergoing chemotherapy in Basrah, Iraq, J Biol Agri Health Care. 2016; 6(18):22-30
37 Williams DW, Lewis MAO.” Isolation and identification ofCandida from the oral cavity”. Oral Diseases. 2000; 6: 3-11.
38 Marsh PD, Martin M. “Oral fungal infections,” in Oral Microbiology, Churchill Livingstone, Edinburgh, UK, 2009;166-179.
39 Odds FC, Bernaerts R. CHROMagar Candida , a new differential isolation medium for presumptive identification of clinically importantCandida species. J Clin Microbiol. 1994; 32: 1923-29.
40 Mirhendi H, Makimura K, Khoramizadeh M, Yamaguchi H. A one-enzyme PCR-RFLP assay for identification of six medically important Candida species. Jpn J Med Mycol. 2006; 47: 225-29.